Leonard E. Post

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Irvine, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Christian Klemt, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Leonard E. Post

Form 4 holding Director

Fulgent Genetics, Inc.

Security class
Common Stock
Shares / value
8,000
Estimated value
$213,516
Report date
01 Aug 2022
Price
$26.69
Ownership
Direct
Form 4 holding Director

CG Oncology, Inc.

Security class
Stock Option
Shares / value
133,077
Estimated value
Report date
16 Dec 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

uniQure N.V.

Security class
Stock Option (Right to Buy)
Shares / value
13,980
Estimated value
Report date
10 Jun 2026
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Director

CG Oncology, Inc.

Security class
Director Stock Option (right to buy)
Shares / value
9,354
Estimated value
Report date
04 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Leonard E. Post

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .